Erythrasma
74 Erythrasma Melissa C. Barkham Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports In its most typical…
Basal cell carcinoma
22 Basal cell carcinoma James M. Spencer and Brooke M. Walls Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
Erythrokeratodermas
76 Erythrokeratodermas Gabriele Richard Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Erythrokeratodermas are a clinically and…
Epidermolysis bullosa acquisita
67 Epidermolysis bullosa acquisita Lawrence S. Chan Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Epidermolysis bullosa…
Cryptococcosis
47 Cryptococcosis Wanda Sonia Robles and Mahreen Ameen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Cryptococcosis…
Chondrodermatitis nodularis helicis chronicus
42 Chondrodermatitis nodularis helicis chronicus Clifford M. Lawrence Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Chondrodermatitis…
Discoid lupus erythematosus
60 Discoid lupus erythematosus Bruce H. Thiers Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Discoid lupus…
Cat scratch disease
37 Cat scratch disease Adam H. Wiener, Bryan A. Selkin and George J. Murakawa Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥…
Chromoblastomycosis
43 Chromoblastomycosis Wanda Sonia Robles and Mahreen Ameen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Chromoblastomycosis…
